The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Sponsored by Caribou Biosciences Inc.

Active
$464.7K Funding
7 People
External

Related Topics

People